Chu-Ya (Jennifer) Yang

Chu-Ya (Jennifer) Yang

Director, External Innovation Partnering at Johnson & Johnson Innovation Asia Pacific @ Johnson & Johnson

About

An experienced scientist, engineer, technology scout, and senior investment analyst with a curious nature, broad functional expertise, and a can-do attitude. Comprehensive knowledge and professional experiences in life science, pharmaceutical, and semiconductor. Filed 2 international patents and published more than 5 peer-reviewed research articles. Skillful and analytical in sourcing and evaluating potential opportunities in healthcare and deep tech for licensing, co-development or investment with successful track records. Made 3 equity investments and established more than 10 research collaborations and partnerships. Effective in managing interdisciplinary projects and intercultural stakeholders in both academia and industry. Striving for excellence and growth.

Country

-

City

China

Industry

Pharmaceuticals

Skill

Project Management, Research and Development (R&D), Technology Scouting, Technology Transfer, Venture Capital, Early-stage Startups, Business Development, Cross-functional Collaborations, Commercialization, Due Diligence, Oncology, Biotechnology, Life Sciences, Medical Devices, Regenerative Medicine, Nanotechnology, Pharmaceutical Industry, Semiconductor Industry, Molecular & Cellular Biology, Drug Discovery

Experience

Johnson & Johnson

Director, External Innovation Partnering at Johnson & Johnson Innovation Asia Pacific

Johnson & Johnson

LinkedIn
2022-9 - 2025-6 · 2 yrs 10 mos

Shanghai, China

National University of Singapore

Director of Graduate Research Innovation Program & Head of Health Technology Commercialization

National University of Singapore

LinkedIn
2022-2 - 2022-8 · 7 mos

Singapore, Singapore

The Industry Liaison Office (ILO) is the technology translation and commercialization arm of the National University of Singapore (NUS). The Graduate Research Innovation Program (GRIP) is the Industry Liaison Office's flagship program of deep tech venture creation. The program provides step-by-step guidance to NUS postgraduate students and researchers to cultivate deep tech entrepreneurs to transform the university's world-class research into their own deep technology start-ups.

iRegene Therapeutics

Business Consultant

iRegene Therapeutics

LinkedIn
2021-11 - 2022-1 · 3 mos

Wuhan, Hubei, China

iRegene Therapeutics was founded in 2017 by a group of brilliant scientists returning from UK to Wuhan, China. The company aims to develop novel therapeutic approaches to solve unmet medical needs. It focuses on the new generation of chemically defined cell therapy with a chemical induce system that enables easy generation of human cell types with high purity. iRegene's lead program is entering phase I clinical trial for Parkinson's disease.

Servier

Director of Search & Evaluaiton, Servier BioInnovation Asia

Servier

LinkedIn
2018-4 - 2021-11 · 3 yrs 8 mos

Beijing City, China

Servier is a French pharmaceutical group governed by a non-profit Foundation. It generated ~ US$5.5 billion revenue in 2020 and has geographic presence in 150 countries.

Ipsen

Director, Asia Pacific, Global Scientific Affairs

Ipsen

LinkedIn
2016-4 - 2018-3 · 2 yrs

Beijing City, China

IPSEN is a global specialty-driven pharmaceutical group that generated ~ US$3.1 billion revenue in 2020 and has a market cap of ~US$7.2 billion.

GRC SinoGreen Fund

Investment Manager

GRC SinoGreen Fund

LinkedIn
2015-2 - 2016-3 · 1 yr 2 mos

Taipei City, Taiwan

GRC SinoGreen Fund is a private equity and venture capital fund that invests in sustainable development and wellness worldwide.

BASF

Assistant Manager, Inorganic Business

BASF

LinkedIn
2011-8 - 2015-2 · 3 yrs 7 mos

Kuanyin, Taiwan

BASF is the largest chemical company in the world that generated sales of ~US$70.9 billion in 2020 and has a market cap of ~US$78.9 billion.

Macro Biologics

Senior Chemist and Consultant

Macro Biologics

LinkedIn
2011-4 - 2012-10 · 1 yr 7 mos

Pasadena, CA USA and Taipei, Taiwan

Amicrobe, Inc. is an advanced biomaterials start-up that developed innovative products to treat wounds and prevent infections.

UC Santa Barbara

Postdoctoral Researcher

UC Santa Barbara

LinkedIn
2009-8 - 2011-3 · 1 yr 8 mos

Santa Barbara, CA USA

Education

UCLA

UCLA

LinkedIn

Biomedical Engineering with emphasis on Biomaterials, Tissue Engineering and Biomechanics

UCLA

UCLA

LinkedIn

Biomedical Engineering with emphasis on Biomedical Instrumentation

National Chung Hsing University

National Chung Hsing University

LinkedIn

Physical Chemistry

National Chung Hsing University

National Chung Hsing University

LinkedIn

Chemistry

UCLA

UCLA

LinkedIn

Chu-Ya (Jennifer) Yang's Contact Information

Email

******@***.com

Phone

(**) *** ****

Find the Right Leads
Find Verified Contact Data

Try with: Jensen Huang @ nvidia.com Click to autofill
LeadContact awards, five-star ratings, and GDPR compliance badges

What LeadContact does well

Find verified emails, phone numbers, and decision-makers with 98% accuracy.

Find Leads

Find Leads

Find the right people by company, role, industry, location, and more.

925M+ professional profiles

Find Leads
Find Emails

Find Emails

Access verified email addresses for your target contacts.

657M+ emails

Find Emails
Find Phone Numbers

Find Phone Numbers

Get cross-validated phone data from multiple top sources.

239M+ phone numbers

Find Phone Numbers

More Accurate. Lower Cost.

Find contact data in 1 tool with 98% accuracy

LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.

LeadContact Logo
Competitor Tools

All these = $289 per month

Great conversations start with the right contact.

It’s time to find yours.